On July 24, 2025, Aptevo Therapeutics Inc. held its Annual Meeting where stockholders voted on eight proposals, including electing directors and approving a reverse stock split of its common stock between 1-for-6 to 1-for-20 ratios. The meeting approved significant matters including the appointment of Baker Tilly as auditors and amendments to the stock incentive plan with strong majority support.